Low-dose CT lung cancer screening for high-risk smoking populations may be controversial, but adding asbestos to the mix could tip the scales in favor of annual imaging. Researchers in Italy and Germany have begun testing screening in patients at risk
Low-dose CT lung cancer screening for high-risk smoking populations may be controversial, but adding asbestos to the mix could tip the scales in favor of annual imaging.
Researchers in Italy and Germany have begun testing screening in patients at risk for lung cancer or malignant pleural mesothelioma following years of asbestos exposure and smoking. After decades of both, a retired worker could have a risk for cancer as great as 87 times that of a person with no exposure to either, according to Dr. Marco Das from Aachen, Germany.
Italian imagers have so far evaluated 943 former asbestos workers with an average 30 years of exposure. Low-dose CT was far more effective at finding nodules than radiography: 778 nodules compared with 459. Among the 943 patients, 46% had some sort of positive finding that was followed up with another CT; 15 patients went on to invasive diagnostic procedures.
In a German study of 100 former power plant workers, almost all of whom were current or former smokers, low-dose 16-row CT found 104 nodules, four cancers, and 48 patients with asbestos-related plaques or fibrosis.
The relatively high number of cancers discovered on the initial screening is mixed news for the researchers: Three of the patients were untreatable, leading one audience member to question whether the screening was worthwhile. With cancer and mesothelioma rates expected to rise over the next 20 years, the screening may eventually pay off in the form of early detection for suspicious nodules, Das said Saturday at the ECR.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.